Purchase of medicinal products as described in Annex I Technical specifications/tender format of the HD. AS East-Tallinn Central Hospital organises a public procurement on the basis of a power of attorney for itself and other contracting authorities (Kuressaare Hospital, AS
and Järvamaa Hospital AS ) in accordance with § 43 of the RHS.
KlooramfenikoolAs described in Annex I to RHAD Technical specifications/tender form
PilokarpiinAs described in Annex I to RHAD Technical specifications/tender form
KarbakoolAs described in Annex I to RHAD Technical specifications/tender form
Atsetasoolamiide, trayAs described in Annex I to RHAD Technical specifications/tender form
Acetazolamide, powder for solution for injectionAs described in Annex I to RHAD Technical specifications/tender form
AtropiinAs described in Annex I to RHAD Technical specifications/tender form
TsüklopentolaatAs described in Annex I to RHAD Technical specifications/tender form
TropikamiidAs described in Annex I to RHAD Technical specifications/tender form
Tropikamiid+fenüülefriin+lidokaiinAs described in Annex I to RHAD Technical specifications/tender form
PhenylephrineAs described in Annex I to RHAD Technical specifications/tender form
TetrakaiinAs described in Annex I to RHAD Technical specifications/tender form
Tobramycin, eye drops, solution 3mg/ml 5mlAs described in Annex I to RHAD Technical specifications/tender form
ProksümetakaiinAs described in Annex I to RHAD Technical specifications/tender form
FluorestseiinAs described in Annex I to RHAD Technical specifications/tender form
Fluorestseiin+oksübuprokaiin+klorbutanoolAs described in Annex I to RHAD Technical specifications/tender form
HüpromelloosAs described in Annex I to RHAD Technical specifications/tender form
AflibertseptAs described in Annex I to RHAD Technical specifications/tender form
BrolutsizumabAs described in Annex I to RHAD Technical specifications/tender form
FaritsimabAs described in Annex I to RHAD Technical specifications/tender form
HüdroksüpropüülmetüültselluloosAs described in Annex I to RHAD Technical specifications/tender form
Naatriumkondroitiinsulfaat/ naatriumhüaluronaatAs described in Annex I to RHAD Technical specifications/tender form
Sodium hyaluronateAs described in Annex I to RHAD Technical specifications/tender form
Tobramütsiin, silmasalv 3mg/g 3,5gAs described in Annex I to RHAD Technical specifications/tender form
Triamtsinoloon atsetoniidAs described in Annex I to RHAD Technical specifications/tender form
Purified perfluoro-n-octane liquidAs described in Annex I to RHAD Technical specifications/tender form
Fluooritud perfluorovesinikAs described in Annex I to RHAD Technical specifications/tender form
Saline, sterile solution 500mlAs described in Annex I to RHAD Technical specifications/tender form
Balansseeritud soolalahusAs described in Annex I to RHAD Technical specifications/tender form
Steriilne silikoonõli 5000-5900mPa-sAs described in Annex I to RHAD Technical specifications/tender form
RiboflaviinAs described in Annex I to RHAD Technical specifications/tender form
Briljantsinine G (trifenüülmetaan)As described in Annex I to RHAD Technical specifications/tender form
TrüpaansinineAs described in Annex I to RHAD Technical specifications/tender form
LevofloksatsiinAs described in Annex I to RHAD Technical specifications/tender form
JoodpovidoonAs described in Annex I to RHAD Technical specifications/tender form
Dexamethasone, solution; 1mg/ml 5mlAs described in Annex I to RHAD Technical specifications/tender form
Deksametasoon, intravitreal implant aplikaatoris 700mcgAs described in Annex I to RHAD Technical specifications/tender form
Dexamethasone+ chloramphenicol, solution 1mg+2mg/ml 10mlAs described in Annex I to RHAD Technical specifications/tender form
Deksametasoon+ klooramfenikool, silmasalvAs described in Annex I to RHAD Technical specifications/tender form